225 related articles for article (PubMed ID: 29866054)
1. MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4.
Lei W; Yan C; Ya J; Yong D; Yujun B; Kai L
BMC Cancer; 2018 Jun; 18(1):631. PubMed ID: 29866054
[TBL] [Abstract][Full Text] [Related]
2. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
[TBL] [Abstract][Full Text] [Related]
3. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
6. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene.
Zang C; Zhao F; Hua L; Pu Y
Cancer Cell Int; 2018; 18():186. PubMed ID: 30479565
[TBL] [Abstract][Full Text] [Related]
7. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
Pu Y; Zhao F; Wang H; Cai W; Gao J; Li Y; Cai S
Oncotarget; 2016 May; 7(19):28420-34. PubMed ID: 27056900
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.
Duan Z; Choy E; Harmon D; Liu X; Susa M; Mankin H; Hornicek F
Mol Cancer Ther; 2011 Aug; 10(8):1337-45. PubMed ID: 21666078
[TBL] [Abstract][Full Text] [Related]
11. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
12. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
Pu Y; Zhao F; Wang H; Cai S
Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
[TBL] [Abstract][Full Text] [Related]
13. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
14.
Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma.
Ye P; Ke X; Zang X; Sun H; Dong Z; Lin J; Wang L; Liu W; Miao G; Tan Y; Tong W; Xiao H; Gao L
Biomed Pharmacother; 2018 May; 101():219-227. PubMed ID: 29494959
[TBL] [Abstract][Full Text] [Related]
16. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L
Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681
[TBL] [Abstract][Full Text] [Related]
17. miR-199a-3p suppresses neuroinflammation by directly targeting MyD88 in a mouse model of bone cancer pain.
Saadh MJ; Rashed AB; Jamal A; Castillo-Acobo RY; Kamal MA; Cotrina-Aliaga JC; Gonzáles JLA; Alothaim AS; Alhoqail WA; Ahmad F; Lakshmaiya N; Amin AH; Younus DG; Rojas GGR; Bahrami A; Akhavan-Sigari R
Life Sci; 2023 Nov; 333():122139. PubMed ID: 37783266
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis.
Wu Z; Gong Q; Yu Y; Zhu J; Li W
BMC Pulm Med; 2020 Jan; 20(1):10. PubMed ID: 31931771
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
20. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
